Can Eye-Tracking reveal if autism therapy is working?

NCT ID NCT05675371

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 2 times

Summary

This completed study tested a device called EarliPoint that uses eye-tracking to monitor changes in children with autism spectrum disorder (ASD) or developmental delays. Researchers followed 325 children aged 15-84 months over 180 days to see if the device could detect improvements in verbal ability, non-verbal learning, and social disability. The goal was to see if this tool could help doctors track treatment progress more objectively.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
EarliPoint System (eye-tracking device)
What this could lead to
If successful, this could provide a simple, objective way to measure how well autism treatments are working over time.
What could go wrong
This was an observational study, not a treatment trial. The device is still new, and it may not reliably track changes in all children.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AJ Drexel Autism Institute, Drexel University

    Philadelphia, Pennsylvania, 19104, United States

  • Cincinnati Children's Hospital Medical Center

    Cincinnati, Ohio, 45229, United States

  • Cortica - Glendale

    Glendale, California, 91203, United States

  • Cortica - Marin

    San Rafael, California, 94903, United States

  • Cortica - Torrance

    Torrance, California, 90503, United States

  • Cortica - Weslake Village

    Westlake Village, California, 91361, United States

  • Emory University/Marcus Autism Center

    Atlanta, Georgia, 30329, United States

  • Munroe-Meyer Institute / University of Nebraska

    Omaha, Nebraska, 68106, United States

  • Southwest Autism Research and Resource Center (SARRC)

    Phoenix, Arizona, 85006, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.